AEO for biotech and life sciences companies
Measure how research platforms and life-science companies are described against the published evidence, partnerships, and quality signals behind the answer.
Life-science categories are precise, evidence-heavy, and easy for general-purpose models to blur. A platform can be visible by name while being misclassified by modality, research use, development stage, or validation status.
A credible AEO program here stays close to public evidence. It monitors category framing, published validation, partnerships, quality systems, and source freshness without generating medical claims or advice.
Prompts that matter here
- leading spatial biology platforms
- how to evaluate lab automation providers
- validated [category] platforms and published evidence
- what evidence supports [brand]'s platform
What to do
- 1
Separate scientific categories
Track modality, research use, workflow, customer type, and development stage separately so unrelated companies do not share one score.
- 2
Connect claims to public evidence
Make publications, validation methods, partnerships, quality scope, and regulatory status explicit and current on owned pages.
- 3
Escalate risky wording
Treat unsupported efficacy, safety, approval, or diagnostic language as a correction workflow—not a marketing opportunity.
Where Recall fits
Recall tracks public brand framing and supporting sources with exact answer excerpts. It does not produce medical claims, patient guidance, or regulatory advice.
Run the free audit — it needs a domain and nothing else. No account, no card, and it reports what the engines can already see about you.
Other industries
/ FAQ
Frequently Asked Questions
- Can biotech companies use AEO without making medical claims?
- Yes. A responsible program can focus on public company classification, research workflows, published evidence, partnerships, quality scope, and source accuracy while excluding patient advice and unsupported efficacy or safety claims.
- What should a biotech team monitor in AI answers?
- Monitor category, modality, intended research use, development or validation stage, named evidence, partnerships, regulatory status, and the source and date behind each material statement.
Ready to track your AI visibility?
Start with the buyer questions closest to revenue or deal flow, preserve every answer and source, then measure whether the work changed the shortlist.